A patient receiving warfarin develops a marked rise in INR after starting a macrolide for Mycoplasma pneumonia. Which macrolide was most likely prescribed, based on cytochrome interactions?
- A Azithromycin
- B Fidaxomicin
- C Roxithromycin
- D Clarithromycin ✓
Explanation
Clarithromycin is a potent inhibitor of CYP3A4 and increases levels of warfarin, statins, carbamazepine and other 3A4 substrates. Azithromycin has negligible CYP450 inhibition, which is why it is preferred when a macrolide must be combined with narrow-index drugs. Roxithromycin has some interaction potential but far less than clarithromycin. Fidaxomicin is a gut-selective Clostridioides difficile agent without systemic CYP effects and is not used for pneumonia.
Reference: Katzung Basic and Clinical Pharmacology, 15th ed.
High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP
Written and medically reviewed by the StethoPrep medical team.